Flucindole

This classification denotes an antipsychotic agent with the molecular formula C14H16F2N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5CYU0D0S8M, chemically known as 3-(dimethylamino)-6,8-difluoro-1,2,3,4-tetrahydrocarbazole but generally known as flucindole, which bears US NIH Compound Identifier 38531. European Medicines Agency schedules Flucindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07670MIG. The term FLUCINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). FLUCINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flucindole under HS 29339990 and SITC 51577. As of Q4 2014, FLUCINDOLE remains the US FDA Preferred Term for this commodity. Flucindole bears US NLM identifiers UMLS ID C0060479 and NCI Concept Code C81582. SMILES: FC1C2[NH]C3C(CC(N(C)C)CC3)C2CC(F)C1.